Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.92
Ingevity Corp reported the three months ended December 31, 2023 results: revenue $371.7 million, net income Net loss of $116.8 million and diluted loss per share of $3.23, EPS diluted loss per share of $3.23. Guidance initiated.
- Period
- the three months ended December 31, 2023
- Revenue
- $371.7 million
- Net income
- Net loss of $116.8 million and diluted loss per share of $3.23
- EPS
- diluted loss per share of $3.23
- Guidance
- initiated
- Result
- preliminary results
Exact text from the filing
843-740-2002 investors@ingevity.com Ingevity reports fourth quarter and full year 2023 financial results Fourth Quarter (comparisons versus prior year period): • Net sales of $371.7 million decreased 3.1% • Net loss of $116.8 million and diluted loss per share of $3.23, including restructuring charges of $107.5 million; adjusted earnings of $7.8 million and diluted
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.92
Ingevity Corp reported the twelve months ended December 31, 2023 results: revenue $1.69 billion, net income Net loss of $5.4 million and diluted loss per share of $0.15, EPS diluted loss per share of $0.15. Guidance initiated.
- Period
- the twelve months ended December 31, 2023
- Revenue
- $1.69 billion
- Net income
- Net loss of $5.4 million and diluted loss per share of $0.15
- EPS
- diluted loss per share of $0.15
- Guidance
- initiated
- Result
- preliminary results
Exact text from the filing
assets to be shut down during the first half of the year • Implemented significant cost savings actions Full Year (comparisons versus prior year period): • Net sales of $1.69 billion increased 1.4% • Net loss of $5.4 million and diluted loss per share of $0.15, including restructuring charges of $145.3 million; adjusted earnings of $144.7 million and diluted
View on SEC.gov